Beijing Sun Novo Pharmaceutical Research Co Ltd (688621) — Free Cash Flow Generation Index
Beijing Sun Novo Pharmaceutical Research Co Ltd (688621) has a Free Cash Flow Generation Index of 0.94x as of September 2025. Free cash flow of CN¥71.38 Million represents 1% of operating cash flow (CN¥76.07 Million). Read 688621 current and long-term liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Beijing Sun Novo Pharmaceutical Research Co Ltd Free Cash Flow Generation Index (2017–2025)
Historical FCF Generation Index trend for Beijing Sun Novo Pharmaceutical Research Co Ltd across 9 annual periods. Explore 688621 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Beijing Sun Novo Pharmaceutical Research Co Ltd (2017–2025)
Year-by-year Free Cash Flow Generation Index for Beijing Sun Novo Pharmaceutical Research Co Ltd. For the full company profile including market capitalisation, see market value of Beijing Sun Novo Pharmaceutical Research.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.54x | CN¥50.78 Million | CN¥93.21 Million | CN¥42.43 Million | ▲ +1035.9% |
| 2024 | 0.05x | CN¥1.54 Million | CN¥32.02 Million | CN¥30.48 Million | ▼ -77.6% |
| 2023 | 0.21x | CN¥19.90 Million | CN¥92.86 Million | CN¥72.96 Million | ▲ +24139.9% |
| 2022 | 0.00x | CN¥91.92K | CN¥103.96 Million | CN¥103.87 Million | ▼ -97.6% |
| 2021 | 0.04x | CN¥3.29 Million | CN¥88.25 Million | CN¥84.96 Million | ▼ -93.5% |
| 2020 | 0.57x | CN¥35.96 Million | CN¥62.99 Million | CN¥27.03 Million | ▲ +3.9% |
| 2019 | 0.55x | CN¥31.30 Million | CN¥56.97 Million | CN¥25.67 Million | ▼ -12.5% |
| 2018 | 0.63x | CN¥27.70 Million | CN¥44.11 Million | CN¥16.41 Million | ▲ +138.9% |
| 2017 | -1.62x | CN¥-12.94 Million | CN¥8.01 Million | CN¥20.96 Million | — |